Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers Journal Article

  

Authors:	Richon, V. M.; Zhou, X.; Rifkind, R. A.; Marks, P. A.
Article Title:	Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
Keywords:	unclassified drug; histone deacetylase inhibitor; cancer growth; nonhuman; antineoplastic agents; neoplasms; animals; cell cycle; apoptosis; animal experiment; animal model; cell differentiation; animalia; cancer inhibition; drug mechanism; enzyme inhibitors; cell transformation; cancer cell; rat; vorinostat; hydroxamic acids; histone deacetylases; histone deacetylase; hydroxamic acid derivative; humans; priority journal; article
Journal Title:	Blood Cells, Molecules, and Diseases
Volume:	27
Issue:	1
ISSN:	1079-9796
Publisher:	Elsevier Inc.
Date Published:	2001-01-01
Start Page:	260
End Page:	264
Language:	English
DOI:	10.1006/bcmd.2000.0376
PUBMED:	11358386
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-0035046529&partnerID=40&md5=cb2e04d32bbebc38a08356e3224e1681
Notes:	Export Date: 21 May 2015 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/73461